0 Items
Toll Free (US) - +1-866-598-1553
sales@precisionbusinessinsights.com
Latin America Cancer Biomarkers Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

Latin America Cancer Biomarkers Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00 – $ 8,900.00

Latin America Cancer Biomarkers Market: By Disease (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Other Diseases), by Type (Protein Biomarkers, Genetic Biomarkers, Other Types), by Profiling Technology (OMICS Technology, Imaging Technology, Immunoassays, Cytogenetics), by Application (Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others) and Geograpy

Request Sample Request Methodology
Request Sample Read More
$ PRICE - $ 3,000.00 – $ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00 – $ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:
Report

Description

Latin America Cancer Biomarkers Market size was valued at USD million in 2021. It is expected to reach a value of USD million by 2028, growing at a CAGR of 10.9% from 2022 to 2028. The market report provides a detailed overview of the Latin America Cancer Biomarkers Market, which has been segmented by disease, type, filing technology, and application. By disease, the Latin American cancer biomarkers market has been segmented into In Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Other Diseases. The Breast Cancer segment is likely the largest and fastest-growing in terms of various disease types. The Latin American cancer biomarkers market has been segmented into Protein Biomarkers, Genetic Biomarkers, and Other Types. The Protein Biomarkers accounted for a significant revenue share in 2021. By profiling technology, the Latin American cancer biomarkers market has been segmented into OMICS Technology, Imaging Technology, Immunoassays, and Cytogenetics. OMICS Technology is expected to account for a significant revenue share from 2022 to 2028. Based on application, the Latin American cancer biomarkers are segmented into Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, and Others. According to precision business insights, the Diagnostics segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In November 2020, Agilent Technologies Inc. launched the Biomarker Pathologist Training Program, a global initiative designed to help pathologists precisely score biomarkers.

Latin America Cancer Biomarkers Market

MARKET SUMMARY
-
10.9%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 10.9%

Latin America Cancer Biomarkers Market

  • The global latin america cancer biomarkers market report gives comprehensive outlook on hydrogen fluoride across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
  • The report on global latin america cancer biomarkers market gives historical, current, and future market sizes (US$ Mn) based on by disease, by type,by profiling technology, by application and geography.
Key Players
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • Qiagen N.V.
  • Illumina
Latin America Cancer Biomarkers Market Drivers

The importance of biological and targeted medicinal therapies, as well as the accuracy, dependability, and technological developments of cancer biomarkers, are expected to drive the growth of the cancer biomarkers market.

Latin America Cancer Biomarkers Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Key

Features of the Report

  • The latin america cancer biomarkers market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Latin America Cancer Biomarkers Market Segmentation

segmentation-block-image

By Disease

    • Prostate Cancer,
    • Breast Cancer,
    • Lung Cancer,
    • Colorectal Cancer,
    • Cervical Cancer,
    • Other Diseases
segmentation-block-image

by Type

    • Protein Biomarkers,
    • Genetic Biomarkers,
    • Other Types
segmentation-block-image

By Application

    • Diagnostics,
    • Drug Discovery and Development,
    • Prognostics,
    • Risk Assessment,
    • Others
Location

GEOGRAPHY

Frequently Asked Questions

The latin america cancer biomarkers market is projected to expand at a CAGR of 10.9% during the forecast period.

The market players profiled in the Latin America cancer biomarkers market report are ​​​Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen N.V., Illumina, GE Healthcare, Agilent Technologies, Biomérieux SA, Merck & Co., Abbott Laboratories, and Becton, Dickinson, and Company.

Report

Table Of Content

1. Executive Summary
2. Latin America Cancer Biomarkers Market Introduction
2.1. Latin America Cancer Biomarkers Market – Taxonomy
2.2. Latin America Cancer Biomarkers Market –Definitions
2.2.1. Disease
2.2.2. Type
2.2.3. Profiling Technology
2.2.4. Application
3. Latin America Cancer Biomarkers Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Latin America Cancer Biomarkers Market Dynamic Factors – Impact Analysis
3.6. Latin America Cancer Biomarkers Market – Competition Landscape
4. Latin America Cancer Biomarkers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028
4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Latin America Cancer Biomarkers Market, By Disease, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1. Prostate Cancer
5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Breast Cancer
5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Lung Cancer
5.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Colorectal Cancer
5.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Cervical Cancer
5.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Other Diseases
5.6.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
6. Latin America Cancer Biomarkers Market Forecast, By Type, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn)
6.1. Protein Biomarkers
6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Genetic Biomarkers
6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Other Types
6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
7. Latin America Cancer Biomarkers Market Forecast, By Profiling Technology, 2017 – 2021 and Forecast, 2020 – 2026 (Revenue, USD Mn)
7.1. OMICS Technology
7.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Imaging Technology
7.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Immunoassays
7.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Cytogenetics
7.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Latin America Cancer Biomarkers Market Forecast, By Application, 2017 – 2021 and Forecast, 2022 – 2028
8.1. Diagnostics
8.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Drug Discovery and Development
8.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Prognostics
8.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Risk Assessment
8.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. Latin America Cancer Biomarkers Market Forecast, By Country, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1. Brazil
9.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Mexico
9.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Argentina
9.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Rest of Latin America
9.4.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Latin America Cancer Biomarkers Market – Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2022 – 2028
10. Latin America Cancer Biomarkers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
10.1. Disease Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Prostate Cancer
10.1.2. Breast Cancer
10.1.3. Lung Cancer
10.1.4. Colorectal Cancer
10.1.5. Cervical Cancer
10.1.6. Other Diseases
10.2. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.2.1. Protein Biomarkers
10.2.2. Genetic Biomarkers
10.2.3. Other Types
10.3. Profiling Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. OMICS Technology
10.3.2. Imaging Technology
10.3.3. Immunoassays
10.3.4. Cytogenetics
10.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Diagnostics
10.4.2. Drug Discovery and Development
10.4.3. Prognostics
10.4.4. Risk Assessment
10.4.5. Others
10.5. Latin America Cancer Biomarkers Market – Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2022 – 2028
10.6. Latin America Cancer Biomarkers Market Dynamics – Trends
11. Latin America Cancer Biomarkers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
11.1. Disease Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Prostate Cancer
11.1.2. Breast Cancer
11.1.3. Lung Cancer
11.1.4. Colorectal Cancer
11.1.5. Cervical Cancer
11.1.6. Other Diseases
11.2. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.2.1. Protein Biomarkers
11.2.2. Genetic Biomarkers
11.2.3. Other Types
11.3. Profiling Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. OMICS Technology
11.3.2. Imaging Technology
11.3.3. Immunoassays
11.3.4. Cytogenetics
11.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Diagnostics
11.4.2. Drug Discovery and Development
11.4.3. Prognostics
11.4.4. Risk Assessment
11.4.5. Others
11.5. Latin America Cancer Biomarkers Market – Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2022 – 2028
11.6. Latin America Cancer Biomarkers Market Dynamics – Trends
12. Latin America Cancer Biomarkers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
12.1. Disease Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Prostate Cancer
12.1.2. Breast Cancer
12.1.3. Lung Cancer
12.1.4. Colorectal Cancer
12.1.5. Cervical Cancer
12.1.6. Other Diseases
12.2. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.2.1. Protein Biomarkers
12.2.2. Genetic Biomarkers
12.2.3. Other Types
12.3. Profiling Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. OMICS Technology
12.3.2. Imaging Technology
12.3.3. Immunoassays
12.3.4. Cytogenetics
12.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Diagnostics
12.4.2. Drug Discovery and Development
12.4.3. Prognostics
12.4.4. Risk Assessment
12.4.5. Others
12.5. Latin America Cancer Biomarkers Market – Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2022 – 2028
12.6. Latin America Cancer Biomarkers Market Dynamics – Trends
13. Latin America Cancer Biomarkers Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)
13.1. Disease Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Prostate Cancer
13.1.2. Breast Cancer
13.1.3. Lung Cancer
13.1.4. Colorectal Cancer
13.1.5. Cervical Cancer
13.1.6. Other Diseases
13.2. Type Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.2.1. Protein Biomarkers
13.2.2. Genetic Biomarkers
13.2.3. Other Types
13.3. Profiling Technology Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. OMICS Technology
13.3.2. Imaging Technology
13.3.3. Immunoassays
13.3.4. Cytogenetics
13.4. Application Analysis 2017 – 2021 and Forecast 2022 – 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Diagnostics
13.4.2. Drug Discovery and Development
13.4.3. Prognostics
13.4.4. Risk Assessment
13.4.5. Others
13.5. Latin America Cancer Biomarkers Market – Opportunity Analysis Index, By Disease, Type, Profiling Technology, Application and Country, 2022 – 2028
13.6. Latin America Cancer Biomarkers Market Dynamics – Trends
14. Competition Landscape 
14.1. Strategic Dashboard of Top Market Players
14.2. Company Profiles (Introduction, Financial Analysis, Disease & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
14.2.1. Thermo Fisher Scientific
14.2.2. Bio-Rad Laboratories
14.2.3. Roche Diagnostics
14.2.4. Qiagen N.V.
14.2.5. Illumina
14.2.6. GE Healthcare
14.2.7. Agilent Technologies
14.2.8. Biomérieux SA
14.2.9. Merck & Co.
14.2.10. Abbott Laboratories
14.2.11. Becton, Dickinson and Company
14.2.12. Quest Diagnostics
15. Research Methodology
16. Key Assumptions and Acronyms
Report

Company Profile

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • Qiagen N.V.
  • Illumina
  • GE Healthcare
  • Agilent Technologies
  • Biomérieux SA
  • Merck & Co.
  • Abbott Laboratories
  • Becton, Dickinson and Company

Description

Latin America Cancer Biomarkers Market size was valued at USD million in 2021. It is expected to reach a value of USD million by 2028, growing at a CAGR of 10.9% from 2022 to 2028. The market report provides a detailed overview of the Latin America Cancer Biomarkers Market, which has been segmented by disease, type, filing technology, and application. By disease, the Latin American cancer biomarkers market has been segmented into In Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Other Diseases. The Breast Cancer segment is likely the largest and fastest-growing in terms of various disease types. The Latin American cancer biomarkers market has been segmented into Protein Biomarkers, Genetic Biomarkers, and Other Types. The Protein Biomarkers accounted for a significant revenue share in 2021. By profiling technology, the Latin American cancer biomarkers market has been segmented into OMICS Technology, Imaging Technology, Immunoassays, and Cytogenetics. OMICS Technology is expected to account for a significant revenue share from 2022 to 2028. Based on application, the Latin American cancer biomarkers are segmented into Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, and Others. According to precision business insights, the Diagnostics segment is predicted to register the fastest growth rate during the forecast period.

Key Development:

In November 2020, Agilent Technologies Inc. launched the Biomarker Pathologist Training Program, a global initiative designed to help pathologists precisely score biomarkers.

Reviews

There are no reviews yet.

Be the first to review “Latin America Cancer Biomarkers Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX

QUICKLINKS
RESEARCH AREAS
PRESS RELEASE
CONTACT US
+1-866-598-1553
EMAIL
sales@precisionbusinessinsights.com
FOLLOW US
QUICK LINKS+
RESEARCH AREAS+
PRESS RELEASE+
CONTACT US+
+1-866-598-1553
sales@precisionbusinessinsights.com
FOLLOW US AT+